Sanctuary Advisors’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Sanctuary Advisors’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-238,588	Closed	-$62.5K	–	2463
2024 Q2	$62.5K	Buy	+238,588	New	+$61.3K	﹤0.01%	2284

Other funds holding SRTAW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

TPCW

TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Sanctuary Advisors's SRTAW Position: Q3 2024 in Review

Sanctuary Advisors sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q3 2024, closing a stake of 238,588 shares — an estimated $62.5K sold.

Sanctuary Advisors first reported a position in SRTAW in Q2 2024 and held it in 1 quarter. The position peaked at $62.5K in Q2 2024. 8 funds tracked by Wall St. Rank hold SRTAW as of Q3 2024.

Sanctuary Advisors reported no remaining Strata Critical Medical Inc Warrants position as of Q3 2024 after selling out during the quarter.
Sanctuary Advisors sold 238,588 Strata Critical Medical Inc Warrants shares in Q3 2024, an estimated $62.5K.
Sanctuary Advisors first reported a position in Strata Critical Medical Inc Warrants in Q2 2024 and held it in 1 quarter.
Sanctuary Advisors's Strata Critical Medical Inc Warrants position peaked at $62.5K in Q2 2024.
8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q3 2024.

Based on Sanctuary Advisors's 13F filing for Q3 2024, filed 25 Nov 2024.